Status:
COMPLETED
End of Life Care in Neonatal Intensive Unite
Lead Sponsor:
Hunan Children's Hospital
Conditions:
Palliative Care
Eligibility:
All Genders
1-3 years
Phase:
NA
Brief Summary
In China, neonatal death on 2019 was 3.5 per 1000 live births, which counts around 57,000 deaths. In mainland China, parents are mostly the main decision-makers in withdrawing life-sustaining treatmen...
Detailed Description
Neonatal death often occurs in tertiary Neonatal Intensive Care Units (NICUs). In China, end-of-life-care (EOLC) does not always involve parents. The aim of this study is to evaluate a parent support ...
Eligibility Criteria
Inclusion
- Infants whose treatment was withdrawn at Corrected Gestational Age (CGA) less than 28 days and their parents.
Exclusion
- Infants with an expected time of death less than three hours after NICU admission. Parents were excluded if they had mental health or language issues that might limit their integration and communication with the healthcare team.
Key Trial Info
Start Date :
May 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05270915
Start Date
May 6 2020
End Date
September 30 2021
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunan Children's Hospital
Changsha, Hunan, China, 410007